A phase I study of cantuzumab mertansine administered as a single intravenous infusion once weekly in patients with advanced solid tumors (Q44968643)

From Wikidata
Jump to navigation Jump to search
scientific article published in July 2004
edit
Language Label Description Also known as
English
A phase I study of cantuzumab mertansine administered as a single intravenous infusion once weekly in patients with advanced solid tumors
scientific article published in July 2004

    Statements

    A phase I study of cantuzumab mertansine administered as a single intravenous infusion once weekly in patients with advanced solid tumors (English)
    Paul R Helft
    Richard L Schilsky
    Frank J Hoke
    Daphne Williams
    Hedy L Kindler
    Evie Sprague
    Mark DeWitte
    Helen K Martino
    John Erickson
    Lini Pandite
    Mark Russo
    John M Lambert
    Maria Howard
    4363-4368

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit